| Tap a line for its trend | Last 12Mto Dec 2025 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22Mar 2022 | FY21 and earlierAlpha Plus |
|---|
| 148.79× | 148.79× | 175.69× | 199.60× | — | FY21 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.57× | 3.86× | 2.71× | 2.32× | — | ||
| 0.81× | 0.81× | 0.78× | 0.68× | — | ||
| 0.22× | 0.22× | 1.21× | 1.31× | 1.65× | ||
| 0.08× | 0.08× | 0.51× | 0.38× | 0.50× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY22 31/03/2022 | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | Last 12M 31/12/2025 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | — | 199.60 | 175.69 | 148.79 | 148.79 | |
| Working Capital Turnover | — | 2.32 | 2.71 | 3.86 | 2.57 | |
| Asset Turnover | — | 0.68 | 0.78 | 0.81 | 0.81 | |
| Cash Conversion (CFO/Net Income) | 1.65 | 1.31 | 1.21 | 0.22 | 0.22 | |
| CFO/EBITDA | 0.50 | 0.38 | 0.51 | 0.08 | 0.08 |